- Home
- ALNY vs RSG Comparison
ALNY vs RSG Comparison
Compare ALNY & RSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALNY
- RSG
- Stock Information
- Founded
- ALNY 2002
- RSG 1996
- Country
- ALNY United States
- RSG United States
- Employees
- ALNY N/A
- RSG N/A
- Industry
- ALNY Biotechnology: Pharmaceutical Preparations
- RSG Environmental Services
- Sector
- ALNY Health Care
- RSG Utilities
- Exchange
- ALNY Nasdaq
- RSG Nasdaq
- Market Cap
- ALNY 60.7B
- RSG 69.7B
- IPO Year
- ALNY 2004
- RSG 1998
- Fundamental
- Price
- ALNY $463.36
- RSG $210.89
- Analyst Decision
- ALNY Strong Buy
- RSG Buy
- Analyst Count
- ALNY 27
- RSG 21
- Target Price
- ALNY $466.46
- RSG $255.62
- AVG Volume (30 Days)
- ALNY 1.0M
- RSG 1.2M
- Earning Date
- ALNY 10-30-2025
- RSG 10-30-2025
- Dividend Yield
- ALNY N/A
- RSG 1.19%
- EPS Growth
- ALNY N/A
- RSG 13.24
- EPS
- ALNY N/A
- RSG 6.76
- Revenue
- ALNY $2,461,963,000.00
- RSG $16,366,000,000.00
- Revenue This Year
- ALNY $60.04
- RSG $5.23
- Revenue Next Year
- ALNY $40.69
- RSG $4.81
- P/E Ratio
- ALNY N/A
- RSG $31.13
- Revenue Growth
- ALNY 5.01
- RSG 5.13
- 52 Week Low
- ALNY $205.87
- RSG $197.61
- 52 Week High
- ALNY $495.55
- RSG $258.75
- Technical
- Relative Strength Index (RSI)
- ALNY 49.33
- RSG 29.40
- Support Level
- ALNY $456.90
- RSG $209.83
- Resistance Level
- ALNY $485.36
- RSG $224.64
- Average True Range (ATR)
- ALNY 16.80
- RSG 3.72
- MACD
- ALNY -1.23
- RSG -0.86
- Stochastic Oscillator
- ALNY 33.70
- RSG 6.44
About ALNY Alnylam Pharmaceuticals Inc.
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia. It also has several clinical programs across various therapeutic areas: genetic medicines; cardio-metabolic diseases; hepatic infectious diseases, and CNS/ocular diseases. Upfront fees from research partnerships have boosted Alnylam's cash levels, and the company stands to see additional milestones and royalties from drugs commercialized under collaboration partnerships.
About RSG Republic Services Inc.
Republic Services is the second-largest integrated provider of traditional solid waste services in the United States, operating roughly 208 active landfills and 248 transfer stations. The company serves residential, commercial, and industrial end markets. It also runs sizable recycling and hazardous waste collection and disposal operations in North America.